Audited Financial Results and Audited Financial Statements
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shree Hari Chemicals Export filed its audited annual results for FY25 with an unmodified (clean) auditor opinion from Kailash Chand Jain & Co. Standalone revenue from operations rose modestly to Rs 14,195.08 lakhs from Rs 13,832.65 lakhs in FY24, about 2.6% growth. Net profit after tax jumped sharply to Rs 512.40 lakhs from around Rs 204.6 lakhs in FY24, roughly 150% growth, helped by lower raw material costs and better other income/expense mix. Despite the strong profit, cash flow from operating activities turned negative at Rs (147.99) lakhs (standalone) and Rs (79.50) lakhs (consolidated), driven by a steep Rs 638 lakh increase in trade receivables and Rs 357 lakh build-up in inventories. The company raised Rs 6.57 crore via zero-coupon convertible debentures in November 2024, of which 4.86 lakh CCDs were converted into equity in March 2025, with no deviation in use of funds.
The strong bottom-line growth is a positive signal for shareholders, but negative operating cash flow suggests profits are tied up in working capital, especially receivables — investors should watch collection trends. The clean audit opinion and successful CCD-to-equity conversion remove short-term governance concerns.